ENOV Enovis Corp Forecast, Technical & Fundamental Analysis
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy... Show more
ENOV is expected to report earnings to fall 4.33% to 85 cents per share on July 30
Q2'26
Est.
$0.85
Q1'26
Beat
by $0.08
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.07
The last earnings report on May 07 showed earnings per share of 88 cents, beating the estimate of 81 cents. With 709.59K shares outstanding, the current market capitalization sits at 1.37B.
A.I. Advisor
published General Information
General Information
a manufacturer of fluid handling and industrial positioning products
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.
Momentum Indicator for ENOV turns negative, indicating new downward trend
ENOV saw its Momentum Indicator move below the 0 level on May 21, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In of the 81 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for ENOV turned negative on May 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
ENOV moved below its 50-day moving average on May 27, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ENOV crossed bearishly below the 50-day moving average on June 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENOV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ENOV broke above its upper Bollinger Band on May 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where ENOV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ENOV advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ENOV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.927) is normal, around the industry mean (10.902). P/E Ratio (0.000) is within average values for comparable stocks, (61.254). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.717). ENOV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.597) is also within normal values, averaging (26.822).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
